Death and thrombo-embolic risk after ablation of atrial flutter compared with atrial fibrillation: a nationwide cohort study

被引:17
|
作者
Vadmann, Henrik [1 ,2 ]
Gorst-Rasmussen, Anders [2 ,3 ]
Hjortshoj, Soren Pihlkjaer [1 ]
Riahi, Sam [1 ]
Lip, Gregory Y. H. [2 ,4 ]
Larsen, Torben Bjerregaard [1 ,2 ]
机构
[1] Aalborg Univ Hosp, Dept Cardiol, Atrial Fibrillat Study Grp, Cardiovasc Res Ctr, Forskningens Hus,Sondre Skovvej 15, DK-9000 Aalborg, Denmark
[2] Aalborg Univ, Fac Hlth, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark
[3] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark
[4] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England
来源
EUROPACE | 2017年 / 19卷 / 05期
关键词
Atrial flutter; Ablation; Death; Thromboembolism; Epidemiology; RADIOFREQUENCY CATHETER ABLATION; STROKE; OUTCOMES;
D O I
10.1093/europace/euw107
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The aim of this study was to investigate whether there is a similar mortality and thrombo-embolic risk, after an atrial ablation procedure, compared with an atrial fibrillation (AF) procedure. Methods and results Using data from nationwide Danish health registries, we identified patients aged 18-75 years undergoing a first-time atrial flutter or an AF ablation procedure in the period 2000-13. Cox proportional hazards regression was used to calculate hazard ratios (HRs) after 5 years of follow-up, adjusting for concomitant risk factors. A total of 1096 and 2266 patients underwent an ablation for atrial flutter or AF, respectively. Age distribution was similar in the two, but atrial flutter patients had more co-morbidities. During 5 years of follow-up, we observed 38 and 36 deaths in the atrial flutter and AF groups, corresponding to an almost two-fold higher mortality rate among atrial flutter patients [crude HR 1.92, 95% confidence interval (CI) 1.22-3.03]. The higher mortality rate persisted after adjustment for age, sex, diabetes mellitus, and hypertension (adjusted HR 1.68, 95% CI 1.05-2.69). The rate of thrombo-embolic events was similar in the two groups (crude HR 1.34, 95% CI 0.71-2.56; adjusted HR 1.22, 95% CI 0.62-2.41). Conclusion In this observational study, patients with atrial flutter had a significantly higher all-cause mortality rate compared with those with AF after an ablation procedure, but similar thrombo-embolic event rates. Future studies should elucidate the reason for this difference in mortality.
引用
收藏
页码:838 / 842
页数:5
相关论文
共 50 条
  • [31] Use of atrioventricular nodal ablation after atrial fibrillation ablation failure: a nationwide cohort study
    Bisson, A.
    Mondout, F.
    Bodin, A.
    Clementy, N.
    Pierre, B.
    Babuty, D.
    Brignole, M.
    Deharo, J. C.
    Fauchier, L.
    EUROPEAN HEART JOURNAL, 2019, 40 : 4170 - 4170
  • [32] Do amiodarone and dronedarone prevent thrombo-embolic stroke by treating the atrial myopathy of patients with atrial fibrillation? A provocative hypothesis
    Packer, Milton
    EUROPACE, 2020, 22 (05): : 681 - 683
  • [33] Atrial fibrillation and risk of stroke: a nationwide cohort study
    Christiansen, Christine Benn
    Gerds, Thomas A.
    Olesen, Jonas Bjerring
    Kristensen, Soren Lund
    Lamberts, Morten
    Lip, Gregory Y. H.
    Gislason, Gunnar H.
    Kober, Lars
    Torp-Pedersen, Christian
    EUROPACE, 2016, 18 (11): : 1689 - 1697
  • [34] Prevention of Atrial Fibrillation After Atrial Flutter Ablation With Ramipril (from the PREFACE Study)
    Guichard, Jean-Baptiste
    Anselme, Frederic
    Defaye, Pascal
    Mansourati, Jacques
    Pavin, Dominique
    Pasquie, Jean-Luc
    Saludas, Yannick
    Barthelemy, Jean-Claude
    Roche, Frederic
    Laporte, Silvy
    Chapelle, Celine
    Garcin, Arnauld
    Romeyer, Cecile
    Isaaz, Karl
    Da Costa, Antoine
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 162 : 73 - 79
  • [35] INCIDENT ATRIAL FIBRILLATION AND THROMBO-EMBOLIC RISK A REPORT FROM MAY MEASUREMENT MONTH 2019 SCREENING PROGRAMME IN BULGARIA
    Postadzhiyan, Arman
    Yotov, Yoto
    Tisheva, Snejana
    Nikolov, Fedya
    Raev, Dimitar
    Gruev, Ivan
    Ramchev, Konstantin
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E128 - E128
  • [36] INCIDENT ATRIAL FIBRILLATION AND THROMBO-EMBOLIC RISK - A REPORT FROM MAY MEASUREMENT MONTH 2019 SCREENING PROGRAMME IN BULGARIA
    Postadzhiyan, Arman
    Yotov, Yoto
    Tisheva, Snejana
    Nikolov, Fedya
    Raev, Dimitar
    Gruev, Ivan
    Ramchev, Konstantin
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E128 - E128
  • [37] Risk of Atrial Fibrillation or Flutter Associated with Periodontitis: A Nationwide, Population-Based, Cohort Study
    Chen, Der-Yuan
    Lin, Ching-Heng
    Chen, Yi-Ming
    Chen, Hsin-Hua
    PLOS ONE, 2016, 11 (10):
  • [38] Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study
    R Erichsen
    C F Christiansen
    T Frøslev
    J Jacobsen
    H T Sørensen
    British Journal of Cancer, 2011, 105 : 881 - 883
  • [39] Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study
    Erichsen, R.
    Christiansen, C. F.
    Froslev, T.
    Jacobsen, J.
    Sorensen, H. T.
    BRITISH JOURNAL OF CANCER, 2011, 105 (07) : 881 - 883
  • [40] Incidence of Atrial Fibrillation After Atrial Flutter Ablation: A Meta-analysis Study
    Pino, Maria Isabel
    Ayoub, Karam
    Llanos, Oscar L.
    Nairooz, Ramez
    Abualsuod, Amjad
    Hakeem, Abdul
    Pothineni, Naga V.
    Paydak, Hakan
    Maskoun, Waddah
    CIRCULATION, 2015, 132